Skip to content

Promoting HPV Vaccine Through Twitter

Feasibility of a Twitter Campaign to Promote HPV Vaccine Uptake Among Racially/Ethnically Diverse Young Adult Women Living in Public Housing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04023955
Enrollment
48
Registered
2019-07-18
Start date
2016-06-01
Completion date
2018-06-10
Last updated
2019-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papilloma Virus

Keywords

vaccination, feasibility, public housing

Brief summary

This study assessed the feasibility of implementing a one-month Twitter campaign to promote knowledge about the human papillomavirus (HPV) vaccine among low-income women living in public housing.

Detailed description

Investigators recruited a convenience sample (n=35) of women ages 18-26 years who resided in public housing in Massachusetts. Investigators assessed the feasibility and acceptability of the campaign. Online assessed changes in HPV knowledge, attitudes, and vaccine intentions before and after the campaign.

Interventions

BEHAVIORALTwitter

Participants received a daily tweet over a period of one-month with educational messages about HPV vaccine and cervical cancer

Sponsors

Tufts University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

English-speaking women Age18-26 years Residents of public housing in two Massachusetts cities

Design outcomes

Primary

MeasureTime frameDescription
Measure of Humanpapilloma VirusVaccine Knowledge3 months13 items that assess knowledge about HPV, the HPV vaccine, and cervical cancer; HPV and cervical cancer risk factors and HPV transmission. Score from 0-100% with higher scores indicating greater knowledge

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026